Zymeworks: Royalty-Backed Biotech Flywheel With Underappreciated ADC Optionality
Zymeworks Inc ZYME
$24.94
▲ +0.61%
(+$0.15)
Open
$24.62
Prev Close
$24.79
Day Range
$24.48 – $25.04
52W Range
$11.02 – $29.75
Market Cap
$1.78B
Beta
1.15
EPS (TTM)
$-1.37
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2019-06-24 |
| Shares Out. | 73,020,000 |
| Website | zymeworks.com/ ↗ |
| Phone | 13022748744 |
Zymeworks Inc is a publicly traded company under the ticker symbol ZYME on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
20 analysts (2026-05-01)